Guidant Prizm Defibrillator Launches Jan. 31; Fourth Quarter Sales Up 16%
This article was originally published in The Gray Sheet
Executive Summary
Shipments of Guidant's Ventak Prizm dual-chamber automatic implantable cardioverter defibrillator are anticipated to begin Jan. 31 following FDA approval via premarket approval application supplement, announced Jan. 24. A list price for the device is still being finalized.
You may also be interested in...
St. Jude Photon ICD PMA Submission Expected By Mid-Year
St. Jude Medical says it expects to file a premarket approval application with FDA for the Photon DR dual-chamber implantable cardioverter defibrillator by mid-year.
St. Jude Photon ICD PMA Submission Expected By Mid-Year
St. Jude Medical says it expects to file a premarket approval application with FDA for the Photon DR dual-chamber implantable cardioverter defibrillator by mid-year.
Guidant Will Move To Protect Atrial Fibrillation Patent Stable - CEO
Guidant is likely to file suit against Medtronic after its anticipated launch of the Jewel AF dual-chamber implantable cardioverter defibrillator (ICD), claiming patent infringement of Guidant's portfolio of atrial fibrillation technology patents.